Stories similar to Cancer Monoclonal Antibodies Market Forecast to 2017:

Cancer Monoclonal Antibodies Market 45 weeks 2 days ago

Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease more efficiently and with enhanced specificity, monoclonal antibodies have become the most widely used cancer therapy. As per the findings of our new research report, cancer monoclonal antibodies provide high specificity to treat tumors and several formats exist for the types of cancer monoclonal antibodies available.

Global Cancer Monoclonal Antibodies Pipeline Analysis Market 1 week 3 days ago

“Global Cancer Monoclonal Antibodies Pipeline Analysis” gives comprehensive insight on the various Monoclonal Antibodies being developed for the treatment of Cancer. Research report covers all the ongoing Monoclonal Antibodies being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Cancer Monoclonal Antibodies market based upon development process.

Future of Monoclonal Antibodies - Market Forecasts to 2015 4 years 6 days ago

GBI Research, the leading business intelligence provider, has released its latest research “The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global monoclonal antibodies market. The report analyzes the markets for monoclonal antibodies in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.

Global Protein Therapeutics Market Forecast to 2015 39 weeks 4 hours ago

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat wide spectrum of diseases, ranging from cancer to metabolic disorders. Despite the post-recessionary impact worldwide causing major slump in the healthcare spending, the protein therapeutics market continued to grow at its retained speed.

Global Monoclonal Antibody Market Analysis 3 years 3 weeks ago

Considered as an indispensable tool in the clinical and biotechnology sector, monoclonal antibodies have testified to be useful in the diagnosis and treatment of many infectious, immune, and neoplastic diseases along with its application in the study of pathogen-host interactions and dialing, detection, & quantification of different molecules.The presence of monoclonal antibodies therapeutics has changed the face of modern medicine in the past decade as they provide innovative and effective therapies for numerous previously refractory illnesses.